Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026

What the insiders did Net selling

By person

22 insiders · 382 transactions
3.5×

Howard W. Robin holds only 3.5 times base salary in stock. $3.96M of shares against $1.11M in salary for 2025.

Salary from the company's own proxy. The shares are what Howard W. Robin last reported holding, valued at $71.98, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Howard W Robin
President & CEO
—
$71.17M (91) scheduled
−$71.17M
55,037
$3.96M
—
Stephen K Doberstein
SVP & Chief Scientific Officer
$259.20K (1)
$30.70M (17) scheduled
−$30.45M
107,668
$7.75M
+468.6%
John Nicholson
SVP & Chief Operating Officer
—
$29.63M (17)
−$29.63M
162,759
$11.72M
+33.4%
Gil M Labrucherie
SVP, COO & CFO
—
$23.30M (44) scheduled
−$23.30M
312,905
$22.52M
+471.5%
Jillian B. Thomsen
Chief Financial Officer
—
$8.79M (29) scheduled
−$8.79M
313,497
$22.57M
+546.0%
Maninder Hora
SVP Pharma Dev & Mfg Ops
—
$8.41M (15) scheduled
−$8.41M
94,694
$6.82M
+75.5%
Robert Chess
Director
—
$7.40M (31) scheduled
−$7.40M
19,299
$1.39M
−74.4%
Christopher A Kuebler
Director
—
$6.08M (5) scheduled
−$6.08M
45,250
$3.26M
+27.5%
Lutz Lingnau
Director
—
$5.23M (8) scheduled
−$5.23M
35,800
$2.58M
+17.6%
Jonathan Zalevsky
Chief R&D Officer
—
$4.92M (39)
−$4.92M
9,570
$688.85K
—
Ivan P. Gergel
SVP & Chief Medical Officer
—
$4.62M (9) scheduled
−$4.62M
56,553
$4.07M
+106.9%
R Scott Greer
Director
—
$4.42M (5) scheduled
−$4.42M
22,239
$1.60M
—
Dennis L Winger
Director
—
$3.87M (4)
−$3.87M
47,750
$3.44M
+21.7%
Roy A Whitfield
Director
$918.46K (4)
$17.10K (1) scheduled
+$901.36K
21,185
$1.52M
—
John Northcott
SVP & Chief Commercial Officer
—
$691.58K (6)
−$691.58K
223,210
$16.07M
—
Mark Andrew Wilson
Chief Legal Officer
—
$673.71K (26)
−$673.71K
21,585
$1.55M
—
Jeffrey Robert Ajer
Director
—
$653.48K (8)
−$653.48K
4,277
$307.86K
—
Myriam Curet
Director
—
$109.24K (4)
−$109.24K
27,418
$1.97M
—
Deep Track Capital, LP entity
10% owner
—
$99.63K (1)
−$99.63K
18,344,000
$1.32B
−0.3%
Karin Eastham
Director
—
$76.77K (1)
−$76.77K
23,233
$1.67M
—
Joseph J Krivulka
Director
—
—
—
82,000
$5.90M
+41.4%
Diana Brainard
Director
—
—
—
3,904
$281.01K
—

No percentages here. This company's share count has moved by a factor of 9.8 over the window, from 19,018,573 to 186,103,588 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.